MENU CLOSE

Disease entities

The CLINUVEL Group works to translate scientific breakthroughs into innovative treatments for the benefit of patient populations with unmet medical needs

Areas of focus

Through diligence and integrity, CLINUVEL enjoins and utilises its expertise to provide longitudinal care over a range of indications affecting the skin and brain, from systemic life-limiting disorders to acute life-threatening conditions.

Discover the patient populations we serve

Erythropoietic protoporphyria (EPP)

INTOLERANT TO LIGHT | Understand EPP, a rare metabolic disorder that causes intolerance to all sources of light

Vitiligo

LOSS OF IDENTITY | Read more about vitiligo, a skin condition resulting in a loss of pigment in the skin, causing a profound psychological and social impact

Arterial ischaemic stroke (AIS)

TIME IS CRITICAL | Read more about AIS, one of the main causes of death and functional inability worldwide

Xeroderma pigmentosum (XP)

IRREPARABLE DAMAGE | Learn more about this debilitating rare disorder which impairs the body’s ability to repair DNA, causing severe skin damage

Variegate porphyria (VP)

ACUTE AND CUTANEOUS | A rare genetic disease that causes both phototoxicity and acute attacks, for which no medical treatment exists

Parkinson’s disease (PD)

FADING MOTOR CONTROL | A degenerative neurological disorder with a higher incidence in fair-skinned individuals

Pharmaceuticals

SKIN & BRAIN | Developing pioneering treatments for patients with severe, unmet medical needs

The Science

BIOMIMICRY | Harnessing and synthesising nature’s ability to provide function and protection for the benefit of patient populations

Go To Top